You are here:Home1/News Release2/FDA Approves LENVIMA? (lenvatinib) plus KEYTRUDA? (pembrolizumab) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma
/wordpress/wp-content/uploads/2021/04/logo3.png00chen, chenyan/wordpress/wp-content/uploads/2021/04/logo3.pngchen, chenyan2019-09-18 00:00:002021-03-18 13:54:40FDA Approves LENVIMA? (lenvatinib) plus KEYTRUDA? (pembrolizumab) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma